Align Sugar-binding transport ATP-binding protein aka MalK1 aka TT_C0211, component of The trehalose/maltose/sucrose/palatinose porter (TTC1627-9) plus MalK1 (ABC protein, shared with 3.A.1.1.24) (Silva et al. 2005; Chevance et al., 2006). The receptor (TTC1627) binds disaccharide alpha-glycosides, namely trehalose (alpha-1,1), sucrose (alpha-1,2), maltose (alpha-1,4), palatinose (alpha-1,6) and glucose (characterized)
to candidate WP_068002943.1 PsAD2_RS04510 ABC transporter ATP-binding protein
Query= TCDB::Q72L52 (376 letters) >NCBI__GCF_001623255.1:WP_068002943.1 Length = 363 Score = 342 bits (877), Expect = 1e-98 Identities = 181/366 (49%), Positives = 243/366 (66%), Gaps = 3/366 (0%) Query: 1 MAKVRLEHVWKRFGKVVAVKDFNLETEDGEFVVFVGPSGCGKTTTLRMIAGLEEISEGNI 60 M ++RLE++ KR+G + NLE E+ EF VFVGPSGCGKTTTLRMIAGLE +S+G I Sbjct: 1 MPRIRLENLVKRYGDFEVLHGINLEMEENEFTVFVGPSGCGKTTTLRMIAGLETVSDGEI 60 Query: 61 YIGDRLVNDVPPKDRDIAMVFQNYALYPHMNVYENMAFGLRLRRYPKDEIDRRVKEAARI 120 YIGDR V+ + PK RD+AMVFQ+YALYPHMNV +NM+F LRL+R P+ EID +V A + Sbjct: 61 YIGDRPVSQLEPKARDLAMVFQDYALYPHMNVAKNMSFALRLQRRPRKEIDEKVGLVAEM 120 Query: 121 LKIEHLLNRKPRELSGGQRQRVAMGRAIVREPKVFLMDEPLSNLDAKLRVEMRAEIAKLQ 180 L + L+RKP ELSGGQRQRVAMGRA+ R+ FL DEPLSNLDAKLR +MRAE+A ++ Sbjct: 121 LGLTKFLHRKPGELSGGQRQRVAMGRALARDAGTFLFDEPLSNLDAKLRCQMRAELAIMR 180 Query: 181 RRLGVTTIYVTHDQVEAMTLGHRIVVMKDGEIQQVDTPLNLYDFPANRFVAGFIGSPSMN 240 +++ IYVTHDQ+EAMTLG RIVVM G IQQ TP L+ PAN+FVAGF+GSP MN Sbjct: 181 QKVRKNMIYVTHDQIEAMTLGDRIVVMNGGYIQQQGTPEELFKQPANKFVAGFLGSPPMN 240 Query: 241 FVRAGVEVQGEKVYLVAPGFRIRANAVLGSALKPYAGKEVWLGVRPEHLGLKGYTTIPEE 300 F+ A ++ G +V++ GF + S ++ V LG+RP L + P+ Sbjct: 241 FLGAKIQDLGGQVFVSGDGFEVALPEERASVALGHSASSVILGIRPSDLHFSPHA--PDH 298 Query: 301 ENVLRGEVEVVEPLGAETEIHVAVNGTLLVAKVDGHAPVKPGDKVELLADTQRLHAFDLE 360 E + +V V E +GA++ + + ++ P+ G+ + + + +H FD E Sbjct: 299 E-AIDLKVIVSEYIGAQSVLLCNCGAQKIEVELKSETPIALGETLRFAVNREAIHLFDSE 357 Query: 361 TDRTIG 366 T+ IG Sbjct: 358 TEVAIG 363 Lambda K H 0.320 0.139 0.400 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 420 Number of extensions: 13 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 376 Length of database: 363 Length adjustment: 30 Effective length of query: 346 Effective length of database: 333 Effective search space: 115218 Effective search space used: 115218 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 49 (23.5 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory